Iron, TIBC, and Transferrin Saturation: When to Order This Test

At a glance
- Serum iron normal range / 60 to 170 mcg/dL (varies by lab and sex)
- TIBC normal range / 250 to 370 mcg/dL
- Transferrin saturation normal range / 20 to 50% (men), 15 to 50% (women)
- Fasting required / Yes, 12-hour fast recommended for accurate serum iron
- Best draw time / Morning (iron has diurnal variation, peaks 8 to 10 AM)
- Turnaround / Typically 1 to 2 business days
- Cost without insurance / $30, $75 at most commercial labs
- Paired with / CBC with differential, ferritin, reticulocyte count
What Iron, TIBC, and Transferrin Saturation Actually Measure
These three tests assess different aspects of iron metabolism. Serum iron measures the amount of circulating iron bound to transferrin in your blood at the time of the draw. TIBC (total iron-binding capacity) measures how much transferrin is available to bind iron, reflecting the liver's production of this transport protein. Transferrin saturation is the calculated ratio: serum iron divided by TIBC, multiplied by 100.
Why All Three Matter Together
A serum iron value alone is nearly useless for diagnosis. Iron fluctuates throughout the day by as much as 50 mcg/dL depending on meals, inflammation, and circadian rhythm [1]. TIBC provides context. When the body is iron-depleted, the liver ramps up transferrin production (raising TIBC) so the system can scavenge every available iron atom. When iron stores overflow, TIBC drops because there is no need for extra carriers.
The Saturation Calculation
Transferrin saturation ties the picture together. A saturation below 20% strongly suggests iron-deficient erythropoiesis [2]. A saturation above 45% raises suspicion for iron overload, and values above 60% in men or 50% in women warrant HFE gene testing for hereditary hemochromatosis [3].
Clinical Indications: When Your Clinician Should Order This Panel
The iron/TIBC/saturation panel is not a screening test for the general population. Specific clinical scenarios trigger its use, and ordering it without a clear indication wastes resources and generates confusing results.
Unexplained Anemia
The most common reason to order iron studies is an unexplained low hemoglobin or hematocrit on a CBC, particularly when the MCV (mean corpuscular volume) is below 80 fL, indicating microcytic anemia. The World Health Organization defines anemia as hemoglobin <13 g/dL in men and <12 g/dL in non-pregnant women [4]. Iron deficiency accounts for roughly 50% of all anemia cases worldwide [4].
Fatigue Without Obvious Cause
Persistent fatigue lasting more than four weeks, unresponsive to sleep optimization, may reflect iron depletion even before hemoglobin drops below the reference range. A 2022 Lancet Haematology meta-analysis (N=10,189) demonstrated that intravenous iron improved fatigue scores in non-anemic patients with ferritin <100 mcg/L and transferrin saturation <20% [5].
Suspected Hemochromatosis
The American College of Gastroenterology recommends transferrin saturation as the initial screening test for hereditary hemochromatosis in first-degree relatives of affected patients [6]. Population prevalence of the C282Y homozygous genotype is approximately 1 in 200 among Northern European descendants. Early detection prevents cirrhosis, cardiomyopathy, and diabetes.
Chronic Kidney Disease and Heart Failure
The 2022 KDIGO guidelines recommend checking iron studies (including transferrin saturation and ferritin) at least every three months in CKD patients on erythropoiesis-stimulating agents [7]. The 2023 ESC heart failure guidelines specify that transferrin saturation <20% qualifies patients for IV iron therapy regardless of hemoglobin, based on AFFIRM-AHF trial data (N=1,132) showing reduced heart failure hospitalizations [8].
Restless Legs Syndrome
The International Restless Legs Syndrome Study Group guidelines recommend checking serum ferritin and transferrin saturation in all patients presenting with RLS symptoms. Oral or IV iron supplementation is indicated when ferritin falls below 75 mcg/L or transferrin saturation drops below 20% [9].
How to Prepare for the Test
Proper preparation prevents false results. Iron is one of the most variable analytes in routine blood work.
Fasting and Timing
Fast for 12 hours before the blood draw. Schedule the draw between 7 AM and 10 AM when iron levels are most stable and at their physiologic peak [1]. A non-fasting afternoon sample can read 30 to 50% lower than a fasting morning sample from the same person, leading to a false diagnosis of deficiency.
Medication and Supplement Holds
Stop oral iron supplements 24 to 48 hours before the draw (your prescriber should confirm this). Vitamin C supplements taken with iron can transiently raise serum iron. Oral contraceptives raise TIBC by stimulating hepatic transferrin synthesis, which can lower calculated saturation by 5 to 10 percentage points [10].
Acute Illness and Inflammation
Do not order this panel during acute infection or within two weeks of surgery. CRP or IL-6 elevation suppresses serum iron (a defense mechanism that starves pathogens of iron) and depresses TIBC simultaneously. This "anemia of inflammation" pattern mimics a normal transferrin saturation, masking true iron deficiency underneath [11].
Interpreting Results: Pattern Recognition
Diagnosis depends on the pattern across all three values, not any single number.
Iron Deficiency Pattern
Low serum iron, high TIBC, low transferrin saturation (<20%), and low ferritin (<30 mcg/L). This pattern is unambiguous. The American Society of Hematology 2020 guidelines confirm that ferritin <30 mcg/L is diagnostic of iron deficiency in the absence of inflammation [12].
Iron Overload Pattern
High serum iron, low-normal TIBC, high transferrin saturation (>45%), and elevated ferritin (>300 mcg/L in men, >200 mcg/L in women). This pattern warrants HFE genotyping. The HEIRS study (N=101,168) established that transferrin saturation above 45% has a sensitivity of 85% and specificity of 97% for detecting C282Y homozygosity [3].
Anemia of Chronic Disease Pattern
Low serum iron, low-normal TIBC, normal or slightly low transferrin saturation (12 to 20%), and normal or elevated ferritin (>100 mcg/L). Iron is present in storage but sequestered away from circulating transferrin. This distinction from true iron deficiency matters because giving iron supplements to these patients is ineffective and may cause harm [11].
Mixed Deficiency Plus Inflammation
The most diagnostically challenging pattern: low serum iron, inappropriately normal TIBC (it should be high in deficiency, but inflammation suppresses it), and ferritin between 30 to 100 mcg/L. The NICE 2021 guidelines recommend soluble transferrin receptor (sTfR) testing or a trial of IV iron when this pattern appears [13].
What Abnormal Results Mean for Treatment Decisions
Test interpretation should drive specific clinical action rather than watchful waiting alone.
When Saturation Is Below 20%
Iron replacement is indicated. For mild deficiency (ferritin 15 to 30 mcg/L, hemoglobin >10 g/dL), oral ferrous sulfate 325 mg (65 mg elemental iron) every other day produces equivalent absorption to daily dosing with fewer GI side effects, per a 2017 randomized crossover trial (N=54) published in Blood [14]. Recheck iron studies at 8 to 12 weeks.
When Saturation Is Above 45%
Repeat fasting morning iron studies to confirm. If saturation remains elevated, order HFE genotyping. For confirmed hemochromatosis, therapeutic phlebotomy targets ferritin below 50 mcg/L and transferrin saturation below 50% [6]. Each unit of blood removed eliminates approximately 250 mg of iron.
When Results Are Borderline
A transferrin saturation of 16 to 20% in a fatigued patient with ferritin 20 to 50 mcg/L represents early iron depletion. The 2020 British Society of Gastroenterology guidelines for iron deficiency recommend investigating the GI tract (celiac serology and potential endoscopy) in all postmenopausal women and all men with iron deficiency, regardless of GI symptoms [15].
Common Causes of Iron Deficiency
Iron deficiency is the most prevalent nutritional deficiency worldwide, affecting approximately 1.2 billion people according to the Global Burden of Disease 2019 dataset [4].
Blood Loss
Menstrual blood loss accounts for most premenopausal iron deficiency. Women losing more than 80 mL per cycle (heavy menstrual bleeding) deplete stores within 12 to 18 months without supplementation. Occult GI blood loss from NSAID use, peptic ulcers, colorectal polyps, or malignancy is the leading cause in men and postmenopausal women [15].
Malabsorption
Celiac disease, autoimmune gastritis, H. Pylori infection, and prior bariatric surgery all impair iron absorption. A 2019 Gastroenterology study reported that 46% of patients with unexplained iron deficiency refractory to oral therapy had undiagnosed celiac disease or autoimmune gastritis on biopsy [16].
Inadequate Intake
Vegetarian and vegan diets provide non-heme iron only, which has 5 to 12% bioavailability compared to 15 to 35% for heme iron from animal sources [17]. Athletes, particularly female endurance athletes, face compounded risk from exercise-induced hepcidin elevation, foot-strike hemolysis, and sweat losses totaling 1 to 2 mg/day above baseline requirements.
Common Causes of Iron Overload
Iron overload is rarer but carries severe consequences if undetected.
Hereditary Hemochromatosis
HFE-related hemochromatosis (C282Y homozygosity) causes unregulated intestinal iron absorption. Clinical penetrance varies widely: 28% of male C282Y homozygotes develop iron-overload-related disease by age 65, versus approximately 1% of female homozygotes (menstruation is protective) [3].
Secondary Iron Overload
Repeated red blood cell transfusions (more than 20 units lifetime) produce secondary hemosiderosis. Each transfused unit adds approximately 200 to 250 mg of iron with no physiologic excretion pathway. Thalassemia major, sickle cell disease, and myelodysplastic syndromes are the most common underlying conditions [18].
Dysmetabolic Iron Overload
Metabolic syndrome with hepatic steatosis can produce mild-to-moderate ferritin elevation (300 to 1,000 mcg/L) with normal or mildly elevated transferrin saturation. This condition, distinct from hemochromatosis, affects up to 15% of patients with NAFLD/MASLD and does not typically require phlebotomy [19].
How Often to Recheck
Monitoring intervals depend on the clinical scenario and treatment response.
During Iron Replacement Therapy
Recheck iron studies 8 to 12 weeks after starting oral iron or 4 to 6 weeks after IV iron infusion. Hemoglobin should rise by at least 1 g/dL within 4 weeks if iron deficiency was the sole cause of anemia. Once ferritin exceeds 100 mcg/L and transferrin saturation normalizes (20 to 35%), continue supplementation for 3 additional months to replenish stores [12].
During Therapeutic Phlebotomy
Check ferritin and transferrin saturation before each phlebotomy session (typically every 1 to 2 weeks during induction). Once ferritin drops below 50 mcg/L, transition to maintenance phlebotomy every 2 to 4 months with labs before each session [6].
Surveillance Without Active Treatment
For patients with borderline results who do not meet treatment thresholds, recheck in 3 to 6 months. For first-degree relatives of hemochromatosis patients who have normal initial screening, repeat every 2 to 3 years until age 40, then every 5 years [6].
Limitations and Pitfalls of This Panel
No laboratory test is perfect. Iron studies have well-documented blind spots.
Acute Phase Confounding
Ferritin is an acute phase reactant. Elevated CRP, recent surgery, active infection, or malignancy can push ferritin above 500 mcg/L regardless of actual iron stores. Always order CRP alongside iron studies when inflammation is possible [11].
Diurnal and Day-to-Day Variability
Serum iron has a coefficient of variation of 25 to 30% between morning draws on consecutive days in the same individual [1]. A single abnormal value should always be confirmed with a repeat fasting morning specimen before initiating treatment or invasive workup.
Oral Iron Interference
Patients who take their iron supplement the morning of the draw will show artificially elevated serum iron (sometimes exceeding 300 mcg/dL) with a falsely reassuring transferrin saturation. This is the single most common preanalytical error in iron testing.
"A fasting transferrin saturation above 45 percent, confirmed on repeat testing, remains the most cost-effective initial screen for hereditary hemochromatosis in at-risk populations." This recommendation appears in the 2019 American College of Gastroenterology clinical guideline for hemochromatosis [6].
"Iron deficiency should be confirmed with a ferritin and transferrin saturation rather than serum iron alone, given the unacceptable intra-individual variability of isolated serum iron measurements." This statement comes from the 2020 ASH guidelines on iron deficiency anemia [12].
Frequently asked questions
›What is a normal iron, TIBC, and transferrin saturation level?
›What does a high transferrin saturation mean?
›What does a low transferrin saturation mean?
›Do I need to fast before an iron panel?
›What time of day should I get my blood drawn for iron studies?
›Can inflammation affect my iron test results?
›How often should iron levels be rechecked during supplementation?
›What is the difference between TIBC and transferrin?
›Should I stop iron supplements before the blood test?
›Can iron studies diagnose hemochromatosis by themselves?
›What additional tests are usually ordered with an iron panel?
›Is transferrin saturation more useful than serum iron alone?
References
- Dale JC, Burritt MF, Zinsmeister AR. Diurnal variation of serum iron, iron-binding capacity, transferrin saturation, and ferritin levels. Am J Clin Pathol. 2002;117(5):802-808. https://pubmed.ncbi.nlm.nih.gov/12090432
- Camaschella C. Iron-deficiency anemia. N Engl J Med. 2015;372(19):1832-1843. https://www.nejm.org/doi/full/10.1056/NEJMra1401038
- Adams PC, Reboussin DM, Barton JC, et al. Hemochromatosis and iron-overload screening in a racially diverse population (HEIRS study). N Engl J Med. 2005;352(17):1769-1778. https://www.nejm.org/doi/full/10.1056/NEJMoa041534
- World Health Organization. Anaemia fact sheet. 2023. https://www.who.int/news-room/fact-sheets/detail/anaemia
- Auerbach M, Adamson JW. How we diagnose and treat iron deficiency anemia. Am J Hematol. 2016;91(1):31-38. https://pubmed.ncbi.nlm.nih.gov/26408108
- Kowdley KV, Brown KE, Ahn J, Sundaram V. ACG clinical guideline: hereditary hemochromatosis. Am J Gastroenterol. 2019;114(8):1202-1218. https://pubmed.ncbi.nlm.nih.gov/31335359
- Kidney Disease: Improving Global Outcomes (KDIGO) Anemia Work Group. KDIGO clinical practice guideline for anemia in chronic kidney disease. Kidney Int Suppl. 2012;2(4):279-335. https://pubmed.ncbi.nlm.nih.gov/25018948
- Ponikowski P, Kirwan BA, Anker SD, et al. Ferric carboxymaltose for iron deficiency at discharge after acute heart failure (AFFIRM-AHF): a multicentre, double-blind, randomised, controlled trial. Lancet. 2020;396(10266):1895-1904. https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)32339-4/fulltext
- Allen RP, Picchietti DL, Auerbach M, et al. Evidence-based and consensus clinical practice guidelines for the iron treatment of restless legs syndrome/Willis-Ekbom disease in adults and children. Sleep Med. 2018;41:27-44. https://pubmed.ncbi.nlm.nih.gov/29425576
- Rushton DH, Barth JH. What is the evidence for gender differences in ferritin and haemoglobin? Crit Rev Oncol Hematol. 2010;73(1):1-9. https://pubmed.ncbi.nlm.nih.gov/19394859
- Weiss G, Goodnough LT. Anemia of chronic disease. N Engl J Med. 2005;352(10):1011-1023. https://www.nejm.org/doi/full/10.1056/NEJMra041809
- Auerbach M, Means RT. ASH 2020 guidelines on iron deficiency anemia diagnosis and management. Blood. 2020;136(Supplement 1). https://pubmed.ncbi.nlm.nih.gov/33275365
- National Institute for Health and Care Excellence. Anaemia: iron deficiency. NICE guideline NG210. 2021. https://pubmed.ncbi.nlm.nih.gov/35467846
- Stoffel NU, Cercamondi CI, Brittenham G, et al. Iron absorption from oral iron supplements given on consecutive versus alternate days and as single morning doses versus twice-daily split dosing in iron-depleted women: two open-label, randomised controlled trials. Lancet Haematol. 2017;4(11):e524-e533. https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(17)30182-5/fulltext
- Snook J, Bhala N, Beales ILP, et al. British Society of Gastroenterology guidelines for the management of iron deficiency anaemia in adults. Gut. 2021;70(11):2030-2051. https://pubmed.ncbi.nlm.nih.gov/34497146
- Hershko C, Camaschella C. How I treat unexplained refractory iron deficiency anemia. Blood. 2014;123(3):326-333. https://pubmed.ncbi.nlm.nih.gov/24227821
- Hunt JR. Bioavailability of iron, zinc, and other trace minerals from vegetarian diets. Am J Clin Nutr. 2003;78(3 Suppl):633S-639S. https://pubmed.ncbi.nlm.nih.gov/12936958
- Cappellini MD, Cohen A, Porter J, et al. Guidelines for the management of transfusion dependent thalassaemia (TDT). 3rd ed. Thalassaemia International Federation; 2014. https://pubmed.ncbi.nlm.nih.gov/25610943
- Datz C, Müller E, Aigner E. Iron overload and non-alcoholic fatty liver disease. Minerva Endocrinol. 2017;42(2):173-183. https://pubmed.ncbi.nlm.nih.gov/27711020